EpiPen Makers, Pfizer Inc. and Mylan Specialty, Fined $625K Over "Deceptive" TV Ad

Pfizer and Mylan Specialty, makers of the EpiPen emergency allergic reaction drug injector, pay the state of Massachusetts $625,000 after the FDA says their week-long television ad misled consumers. EpiPen providers Pfizer (NYSE:PFE) and Mylan Specialty agreed to a $625,000 settlement to close the books on charges that they misled consumers about the efficacy of the emergency allergy medication dispenser. The companies in April aired a television commercial, and ran a parallel print ad, that showed a mother and her son discussing the EpiPen system on the way to a birthday party.

Help employers find you! Check out all the jobs and post your resume.